Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
The Plant Cell
|
July 18, 2002
Role of SCF ubiquitin-ligase and the COP9 signalosome in the N gene-mediated resistance response to Tobacco mosaic virus
Yule Liu, Michael Schiff, Giovanna Serino, et al.
Journal of Clinical Medicine
|
July 2, 2020
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
Yannick Degboé, Michael Schiff, Michael Weinblatt, et al.
The Journal of Biological Chemistry
|
October 30, 2003
Molecular chaperone Hsp90 associates with resistance protein N and its signaling proteins SGT1 and Rar1 to modulate an innate immune response in plants
Yule Liu, Tessa Burch-Smith, Michael Schiff, et al.
Journal of Gastrointestinal Cancer
|
February 24, 2010
Clinical outcomes of using a conservative approach of late esophageal stent placement in palliation of malignant dysphagia
Krishdeep Singh Chadha, Michael Schiff, Michael D Sitrin, et al.
RMD Open
|
February 27, 2018
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
Joel M Kremer, Michael Schiff, David Muram, et al.
The Plant Journal : for Cell and Molecular Biology
|
December 17, 2003
Two MAPK cascades, NPR1, and TGA transcription factors play a role in Pto-mediated disease resistance in tomato
Sophia K Ekengren, Yule Liu, Michael Schiff, et al.
Cell
|
May 24, 2005
Autophagy regulates programmed cell death during the plant innate immune response
Yule Liu, Michael Schiff, Kirk Czymmek, et al.
Patient Preference and Adherence
|
August 3, 2019
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices
Marco Boeri, Boglarka Szegvari, Brett Hauber, et al.
Advances in Therapy
|
February 3, 2016
Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis
Michael Schiff, Joe Koo, Erik Jin, et al.
The Journal of Rheumatology
|
December 7, 2005
A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis
Daniel E Furst, Roy Fleischmann, Elliott Kopp, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
The Plant Cell
|
July 18, 2002
Role of SCF ubiquitin-ligase and the COP9 signalosome in the N gene-mediated resistance response to Tobacco mosaic virus
Yule Liu, Michael Schiff, Giovanna Serino, et al.
Journal of Clinical Medicine
|
July 2, 2020
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
Yannick Degboé, Michael Schiff, Michael Weinblatt, et al.
The Journal of Biological Chemistry
|
October 30, 2003
Molecular chaperone Hsp90 associates with resistance protein N and its signaling proteins SGT1 and Rar1 to modulate an innate immune response in plants
Yule Liu, Tessa Burch-Smith, Michael Schiff, et al.
Journal of Gastrointestinal Cancer
|
February 24, 2010
Clinical outcomes of using a conservative approach of late esophageal stent placement in palliation of malignant dysphagia
Krishdeep Singh Chadha, Michael Schiff, Michael D Sitrin, et al.
RMD Open
|
February 27, 2018
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics
Joel M Kremer, Michael Schiff, David Muram, et al.
The Plant Journal : for Cell and Molecular Biology
|
December 17, 2003
Two MAPK cascades, NPR1, and TGA transcription factors play a role in Pto-mediated disease resistance in tomato
Sophia K Ekengren, Yule Liu, Michael Schiff, et al.
Cell
|
May 24, 2005
Autophagy regulates programmed cell death during the plant innate immune response
Yule Liu, Michael Schiff, Kirk Czymmek, et al.
Patient Preference and Adherence
|
August 3, 2019
From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices
Marco Boeri, Boglarka Szegvari, Brett Hauber, et al.
Advances in Therapy
|
February 3, 2016
Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis
Michael Schiff, Joe Koo, Erik Jin, et al.
The Journal of Rheumatology
|
December 7, 2005
A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis
Daniel E Furst, Roy Fleischmann, Elliott Kopp, et al.
Page
of 9